Do chronic myeloid leukemia patients with late "warning" responses benefit from "watch and wait" or switching therapy to a second generation tyrosine kinase inhibitor?
Identificadores
Identificadores
Fecha de publicación
2014Título de revista
AMERICAN JOURNAL OF HEMATOLOGY
Tipo de contenido
Artigo